Table 1.
Serum | Lung tissue | BALF | ||||
---|---|---|---|---|---|---|
IPF (n = 10) | Control (n = 10) | IPF (n = 10) | Control (n = 10) | IPF (n = 10) | Control (n = 10) | |
Age | 58.43 ± 2.432 | 60.32 ± 3.483 | 48.23 ± 2.512 | 50.28 ± 2.942 | 56.25 ± 1.453 | 61.25 ± 2.542 |
Sex | ||||||
Male | 6 (60%) | 5 (50%) | 3 (30%) | 5 (50%) | 6 (60%) | 5 (50%) |
Female | 4 (40%) | 5 (50%) | 7 (70%) | 5 (50%) | 4 (40%) | 5 (50%) |
FVC, % | 56.03 ± 4.254 | NA | 57.16 ± 3.657 | NA | 46.43 ± 3.537 | NA |
DLCO, % | 43. 74 ± 3.232 | NA | 41.13 ± 3.475 | NA | 39.48 ± 4.743 | NA |
IPF idiopathic pulmonary fibrosis, BALF bronchoalveolar lavage fluid, DLCO diffusion capacity for carbon monoxide, FVC forced vital capacity.